Key Points

  • Armitage studied economics at the University of Cambridge and began his career in finance as a research analyst before joining Egerton Capital in 1994.
  • As president of Egerton Capital, Armitage is responsible for overseeing the company's investment strategies and operations.
  • Armitage is also a member of the board of directors for several other companies, including Virgin Money and the UK government's Green Investment Bank.

John Armitage is the current president of Egerton Capital, a leading global alternative asset management firm. Armitage has been with Egerton Capital since its inception in 1994, and has played a crucial role in the company's growth and success over the years.

Born in 1964, Armitage studied economics at the University of Cambridge, where he graduated with a first-class degree. After completing his studies, he began his career in finance as a research analyst at a leading investment bank, before joining Egerton Capital in 1994.

Egerton Capital

As president of Egerton Capital, John Armitage is responsible for overseeing the firm's investment strategies and operations. Under his leadership, the company has consistently delivered strong returns for its investors and has established itself as one of the top alternative asset management firms in the world.

In addition to his work at Egerton Capital, Armitage is also a member of the board of directors for several other companies, including Virgin Money and the UK government's Green Investment Bank. He is highly regarded in the financial industry for his expertise and experience, and is often sought out for his insights on the markets and investment trends.

Aside from his professional accomplishments, Armitage is also known for his philanthropic efforts.

He is a passionate supporter of several charitable organizations, and has donated generously to causes such as education and healthcare.

Investors interested in tracking Armitage's portfolio can use TickerTracker.io to do so. TickerTracker.io allows investors to track portfolios and configure alerts to receive notifications when a portfolio is updated. This can be useful for investors who want to keep track of Armitage's investment activities and potentially follow his lead.

John Armitage is a highly accomplished and respected figure in the financial industry, and his leadership and expertise have played a key role in the success of Egerton Capital. He is also known for his philanthropic efforts, and continues to make a positive impact on both the business world and society as a whole.



About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.4B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO